Danlou Tablet May Alleviate Vascular Injury Caused by Chronic Intermittent Hypoxia through Regulating FIH-1, HIF-1, and Angptl4.
Yi RongQian WuJingjing TangZhiguo LiuQianyu LvXuejiao YeYu DongYuebo ZhangGuangxi LiShihan WangPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
DLT improved vascular damage by improving the increase in blood lipids induced by CIH, potentially by upregulating FIH-1 and downregulating HIF-1 and Angptl4 in adipose tissue. Therefore, DLT may be a promising agent for the prevention and treatment of CIH-induced vascular injury.